{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:19:45Z","timestamp":1717460385291},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00393-024-01521-y","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:01:46Z","timestamp":1716825706000},"page":"393-400","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bedeutung lysosomaler Speicherkrankheiten in der Rheumatologie","Importance of lysosomal storage diseases in rheumatology"],"prefix":"10.1007","volume":"83","author":[{"given":"Charlotte","family":"Aries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Muschol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"1521_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0025-4","author":"FM Platt","year":"2018","unstructured":"Platt\u00a0FM, d\u2019Azzo\u00a0A, Davidson\u00a0BL, Neufeld\u00a0EF, Tifft\u00a0CJ (2018) Lysosomal storage diseases. Nat Rev Dis Prim. https:\/\/doi.org\/10.1038\/s41572-018-0025-4","journal-title":"Nat Rev Dis Prim"},{"key":"1521_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/jpc.13122","volume":"52","author":"RA James","year":"2016","unstructured":"James\u00a0RA, Singh-Grewal\u00a0D, Lee\u00a0SJ, McGill\u00a0J, Adib\u00a0N (2016) Lysosomal storage disorders: a\u00a0review of the musculoskeletal features. J\u00a0Paediatr Child Health 52:262\u2013271. https:\/\/doi.org\/10.1111\/jpc.13122","journal-title":"J Paediatr Child Health"},{"key":"1521_CR3","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/diagnostics11020273","volume":"11","author":"B Celik","year":"2021","unstructured":"Celik\u00a0B, Tomatsu\u00a0SC, Tomatsu\u00a0S, Khan\u00a0SA (2021) Epidemiology of mucopolysaccharidoses update. Diagnostics 11:2021. https:\/\/doi.org\/10.3390\/diagnostics11020273","journal-title":"Diagnostics"},{"key":"1521_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9081838","volume":"9","author":"CS Hampe","year":"2020","unstructured":"Hampe\u00a0CS, Eisengart\u00a0JB, Lund\u00a0TC, Orchard\u00a0PJ, Swietlicka\u00a0M, Wesley\u00a0J, McIvor\u00a0RS (2020) Mucopolysaccharidosis type\u00a0I: a\u00a0review of the natural history and molecular pathology. Cells 9:1\u201326. https:\/\/doi.org\/10.3390\/cells9081838","journal-title":"Cells"},{"key":"1521_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jbspin.2017.01.008","volume":"84","author":"S Mitrovic","year":"2017","unstructured":"Mitrovic\u00a0S, Gouze\u00a0H, Gossec\u00a0L, Schaeverbeke\u00a0T, Fautrel\u00a0B (2017) Mucopolysaccharidoses seen in adults in rheumatology. Joint Bone Spine 84:663\u2013670. https:\/\/doi.org\/10.1016\/j.jbspin.2017.01.008","journal-title":"Joint Bone Spine"},{"key":"1521_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ymgmr.2016.07.006","volume":"8","author":"S Bruni","year":"2016","unstructured":"Bruni\u00a0S, Lavery\u00a0C, Broomfield\u00a0A (2016) The diagnostic journey of patients with mucopolysaccharidosis I: a\u00a0real-world survey of patient and physician experiences. Mol Genet Metab Reports 8:67\u201373. https:\/\/doi.org\/10.1016\/j.ymgmr.2016.07.006","journal-title":"Mol Genet Metab Reports"},{"key":"1521_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-7-18","volume":"7","author":"R Cimaz","year":"2009","unstructured":"Cimaz\u00a0R, Coppa\u00a0GV, Kon\u00e9-Paut\u00a0I, Link\u00a0B, Pastores\u00a0GM, Elorduy\u00a0MR, Spencer\u00a0C, Thorne\u00a0C, Wulffraat\u00a0N, Manger\u00a0B (2009) Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol 7:1\u20138. https:\/\/doi.org\/10.1186\/1546-0096-7-18","journal-title":"Pediatr Rheumatol"},{"key":"1521_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11020189","volume":"11","author":"CS Hampe","year":"2021","unstructured":"Hampe\u00a0CS, Wesley\u00a0J, Lund\u00a0TC, Orchard\u00a0PJ, Polgreen\u00a0LE, Eisengart\u00a0JB, McLoon\u00a0LK, Cureoglu\u00a0S, Schachern\u00a0P, McIvor\u00a0RS (2021) Mucopolysaccharidosis type\u00a0I:\u00a0Current treatments, limitations and prospects for improvement. Biomolecules 11:1\u201325. https:\/\/doi.org\/10.3390\/biom11020189","journal-title":"Biomolecules"},{"key":"1521_CR9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/1756-185X.14620","volume":"26","author":"S Chopra","year":"2023","unstructured":"Chopra\u00a0S, Maheshwari\u00a0A, Verma\u00a0A, Kannepalli\u00a0A, Mahto\u00a0D (2023) Mucolipidosis: A\u00a0mimicker of juvenile idiopathic arthritis. Int J Rheum Dis 26:1363\u20131367. https:\/\/doi.org\/10.1111\/1756-185X.14620","journal-title":"Int J Rheum Dis"},{"key":"1521_CR10","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41436-021-01244-4","volume":"23","author":"EJ Dogterom","year":"2021","unstructured":"Dogterom\u00a0EJ, Wagenmakers\u00a0MAEM, Wilke\u00a0M, Demirdas\u00a0S, Muschol\u00a0NM, Pohl\u00a0S, van der Meijden\u00a0JC, Rizopoulos\u00a0D, van der Ploeg\u00a0AT, Oussoren\u00a0E (2021) Mucolipidosis type\u00a0II and type\u00a0III: a\u00a0systematic review of 843 published cases. Genet Med 23:2047\u20132056. https:\/\/doi.org\/10.1038\/s41436-021-01244-4","journal-title":"Genet Med"},{"key":"1521_CR11","unstructured":"Muschol\u00a0NM, Rudolph\u00a0C, Braulke\u00a0T (2022) Chapter 20.1 Defects in Transport: Mucolipidosis II, Mucolipidosis III alpha\/beta and Mucolipidosis III gamma. In: Mehta\u00a0AB, Winchester\u00a0B (Hrsg) Lysosomal Storage Disorders \u2013 A Practical Guide, 2. Aufl. Hoboken, NJ: Wiley-Blackwell., S\u00a0221\u2013225"},{"key":"1521_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10545-018-0186-z","volume":"41","author":"E Oussoren","year":"2018","unstructured":"Oussoren\u00a0E, van Eerd\u00a0D, Murphy\u00a0E, Lachmann\u00a0R, van der Meijden\u00a0JC, Hoefsloot\u00a0LH, Verdijk\u00a0R, Ruijter\u00a0GJG, Maas\u00a0M, Hollak\u00a0CEM, Langendonk\u00a0JG, van der Ploeg\u00a0AT, Langeveld\u00a0M (2018) Mucolipidosis type\u00a0III, a\u00a0series of adult patients. J\u00a0Inherit Metab Dis 41:839\u2013848. https:\/\/doi.org\/10.1007\/s10545-018-0186-z","journal-title":"J Inherit Metab Dis"},{"key":"1521_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21186812","volume":"21","author":"SA Khan","year":"2020","unstructured":"Khan\u00a0SA, Tomatsu\u00a0SC (2020) Mucolipidoses overview: past, present, and future. Int J Mol Sci 21:1\u201320. https:\/\/doi.org\/10.3390\/ijms21186812","journal-title":"Int J Mol Sci"},{"key":"1521_CR14","doi-asserted-by":"crossref","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, De Villemeur TB, Berger MG (2017) A review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 18:","DOI":"10.3390\/ijms18020441"},{"key":"1521_CR15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jbmr.3734","volume":"34","author":"D Hughes","year":"2019","unstructured":"Hughes\u00a0D, Mikosch\u00a0P, Belmatoug\u00a0N, Carubbi\u00a0F, Cox\u00a0TM, Goker-Alpan\u00a0O, Kindmark\u00a0A, Mistry\u00a0PK, Poll\u00a0L, Weinreb\u00a0N, Deegan\u00a0P (2019) Gaucher disease in bone: from pathophysiology to practice. J\u00a0Bone Miner Res 34:996\u20131013. https:\/\/doi.org\/10.1002\/jbmr.3734","journal-title":"J Bone Miner Res"},{"key":"1521_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2022.03.001","volume":"136","author":"NJ Weinreb","year":"2022","unstructured":"Weinreb\u00a0NJ, Goker-Alpan\u00a0O, Kishnani\u00a0PS, Longo\u00a0N, Burrow\u00a0TA, Bernat\u00a0JA, Gupta\u00a0P, Henderson\u00a0N, Pedro\u00a0H, Prada\u00a0CE, Vats\u00a0D, Pathak\u00a0RR, Wright\u00a0E, Ficicioglu\u00a0C (2022) The diagnosis and management of gaucher disease in pediatric patients: where do we go from here? Mol Genet Metab 136:4\u201321. https:\/\/doi.org\/10.1016\/j.ymgme.2022.03.001","journal-title":"Mol Genet Metab"},{"key":"1521_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/BOR.0b013e3282f169fe","volume":"20","author":"H Michels","year":"2008","unstructured":"Michels\u00a0H, Mengel\u00a0E (2008) Lysosomal storage diseases as differential diagnoses to rheumatic disorders. Curr Opin Rheumatol 20:76\u201381. https:\/\/doi.org\/10.1097\/BOR.0b013e3282f169fe","journal-title":"Curr Opin Rheumatol"},{"key":"1521_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10354-010-0841-y","volume":"160","author":"P Mikosch","year":"2010","unstructured":"Mikosch\u00a0P, Hughes\u00a0D (2010) An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr 160:609\u2013624. https:\/\/doi.org\/10.1007\/s10354-010-0841-y","journal-title":"Wien Med Wochenschr"},{"key":"1521_CR19","doi-asserted-by":"publisher","first-page":"175023","DOI":"10.1016\/j.ejphar.2022.175023","volume":"926","author":"W Kong","year":"2022","unstructured":"Kong\u00a0W, Lu\u00a0C, Ding\u00a0Y, Meng\u00a0Y (2022) Update of treatment for Gaucher disease. Eur J Pharmacol 926:175023. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175023","journal-title":"Eur J Pharmacol"},{"key":"1521_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada\u00a0M, Pagliardini\u00a0S, Yasuda\u00a0M, Tukel\u00a0T, Thiagarajan\u00a0G, Sakuraba\u00a0H, Ponzone\u00a0A, Desnick\u00a0RJ (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79:31\u201340. https:\/\/doi.org\/10.1086\/504601","journal-title":"Am J Hum Genet"},{"key":"1521_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"A Ortiz","year":"2018","unstructured":"Ortiz\u00a0A, Germain\u00a0DP, Desnick\u00a0RJ, Politei\u00a0J, Mauer\u00a0M, Burlina\u00a0A, Eng\u00a0C, Hopkin\u00a0RJ, Laney\u00a0D, Linhart\u00a0A, Waldek\u00a0S, Wallace\u00a0E, Weidemann\u00a0F, Wilcox\u00a0WR (2018) Fabry disease revisited: Management and treatment recommendations for adult patients. Mol Genet Metab 123:416\u2013427. https:\/\/doi.org\/10.1016\/j.ymgme.2018.02.014","journal-title":"Mol Genet Metab"},{"key":"1521_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/cge.13546","volume":"96","author":"DP Germain","year":"2019","unstructured":"Germain\u00a0DP, Fouilhoux\u00a0A, Decramer\u00a0S, Tardieu\u00a0M, Pillet\u00a0P, Fila\u00a0M, Rivera\u00a0S, Desch\u00eanes\u00a0G, Lacombe\u00a0D (2019) Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients. Clin Genet 96:107\u2013117. https:\/\/doi.org\/10.1111\/cge.13546","journal-title":"Clin Genet"},{"key":"1521_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-013-0365-4","author":"M Biegstraaten","year":"2013","unstructured":"Biegstraaten\u00a0M, Linthorst\u00a0GE, Van Schaik\u00a0IN, Hollak\u00a0CEM (2013) Fabry disease: a\u00a0rare cause of neuropathic pain. Curr Pain Headache Rep. https:\/\/doi.org\/10.1007\/s11916-013-0365-4","journal-title":"Curr Pain Headache Rep"},{"key":"1521_CR24","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate\u00a0YA, Hopkin\u00a0RJ (2008) Fabry\u2019s disease. Lancet 372:1427\u20131435. https:\/\/doi.org\/10.1016\/S0140-6736(08)61589-5","journal-title":"Lancet"},{"key":"1521_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2022.07.010","volume":"137","author":"DP Germain","year":"2022","unstructured":"Germain\u00a0DP, Altarescu\u00a0G, Barriales-Villa\u00a0R, Mignani\u00a0R, Pawlaczyk\u00a0K, Pieruzzi\u00a0F, Terryn\u00a0W, Vujkovac\u00a0B, Ortiz\u00a0A (2022) An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease. Mol Genet Metab 137:49\u201361. https:\/\/doi.org\/10.1016\/j.ymgme.2022.07.010","journal-title":"Mol Genet Metab"},{"key":"1521_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mgg3.2029","volume":"10","author":"L Wagenh\u00e4user","year":"2022","unstructured":"Wagenh\u00e4user\u00a0L, Rickert\u00a0V, Sommer\u00a0C, Wanner\u00a0C, Nordbeck\u00a0P, Rost\u00a0S, \u00dc\u00e7eyler\u00a0N (2022) X\u2011chromosomal inactivation patterns in women with Fabry disease. Mol Genet Genomic Med 10:1\u201315. https:\/\/doi.org\/10.1002\/mgg3.2029","journal-title":"Mol Genet Genomic Med"},{"key":"1521_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02392-9","volume":"17","author":"M Beck","year":"2022","unstructured":"Beck\u00a0M, Ramaswami\u00a0U, Hernberg-St\u00e5hl\u00a0E, Hughes\u00a0DA, Kampmann\u00a0C, Mehta\u00a0AB, Nicholls\u00a0K, Niu\u00a0DM, Pintos-Morell\u00a0G, Reisin\u00a0R, West\u00a0ML, Schenk\u00a0J, Anagnostopoulou\u00a0C, Botha\u00a0J, Giugliani\u00a0R (2022) Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a\u00a0global patient registry. Orphanet J Rare Dis 17:1\u201314. https:\/\/doi.org\/10.1186\/s13023-022-02392-9","journal-title":"Orphanet J Rare Dis"},{"key":"1521_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00109-020-01935-6","volume":"98","author":"AF Leal","year":"2020","unstructured":"Leal\u00a0AF, Espejo-Mojica\u00a0AJ, S\u00e1nchez\u00a0OF, Ram\u00edrez\u00a0CM, Reyes\u00a0LH, Cruz\u00a0JC, Alm\u00e9ciga-D\u00edaz\u00a0CJ (2020) Lysosomal storage diseases: current therapies and future alternatives. J\u00a0Mol Med 98:931\u2013946. https:\/\/doi.org\/10.1007\/s00109-020-01935-6","journal-title":"J Mol Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01521-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:05:53Z","timestamp":1717412753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01521-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01521-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"24 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>C.\u00a0Aries<\/b>: A.\u00a0Finanzielle Interessen: Amicus Therapeutics GmbH (Kongressteilnahme, Hotel- und Reisekostenerstattungen), Sanofi Aventis Deutschland GmbH (Vortragshonorare), Takeda Pharma Vertrieb GmbH & Co. KG (Vortragshonorare, Hotel- und Reisekostenerstattungen).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztin in Weiterbildung am Zentrum f\u00fcr lysosomale Speicherkrankheiten, Klinik und Poliklinik f\u00fcr Kinder- und Jugendmedizin, Universit\u00e4tsklinikum Hamburg-Eppendorf | Mitgliedschaft: DGKJ. <b>C.\u00a0Rudolph<\/b>: A.\u00a0Finanzielle Interessen: C.\u00a0Rudolph gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Wissenschaftliche Angestellte, Universit\u00e4tsklinikum Hamburg-Eppendorf. <b>N.\u00a0Muschol<\/b>: A.\u00a0Finanzielle Interessen: Amicus Therapeutics GmbH (Beraterhonorare, Vortragshonorare, Kongressteilnahme, Hotel- und Reisekostenerstattungen); Chiesi GmbH (Beraterhonorare, Vortragshonorare, Hotel- und Reisekostenerstattungen); Sanofi Aventis Deutschland GmbH (Beraterhonorare, Vortragshonorare, Hotel- und Reisekostenerstattungen); Takeda Pharma Vertrieb GmbH & Co. KG (Beraterhonorare, Vortragshonorare, Hotel- und Reisekostenerstattungen).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE), Klinik und Poliklinik f\u00fcr Kinder- und Jugendmedizin (Kinder UKE), Hamburg | Sprecherin Internationales Zentrum f\u00fcr Lysosomale Speicherkrankheiten (ICLD) als Kompetenzzentrum des Martin Zeitz Centrum f\u00fcr seltene Erkrankungen (MZCSE); Vorstandsmitglied der European Study Group on Lysosomal Diseases (ESGLD).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}